83 FR 31762 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 131 (July 9, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 131 (July 9, 2018)
| Page Range | 31762-31763 | |
| FR Document | 2018-14648 |
[Federal Register Volume 83, Number 131 (Monday, July 9, 2018)] [Notices] [Pages 31762-31763] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-14648] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Environmental Determinants of Diabetes. Date: July 9, 2018. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301- 594-8886, sanoviche@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Review of Planning Grant Application (U34). Date: July 12, 2018. Time: 6:00 p.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 402-7172, woynarowskab@niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK U34 Telephone Review. Date: July 13, 2018. Time: 3:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4719, guox@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing [[Page 31763]] limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Mechanisms and Treatments of Lower Urinary Tract Dysfunction after Spinal Cord Injury. Date: July 23, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Paul A. Rushing, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8895, rushingp@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Urologic P20 Applications. Date: August 2-3, 2018. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Ryan G. Morris, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301- 594-4721, ryan.morris@nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Diabetes Ancillary Studies (R01). Date: August 2, 2018. Time: 1:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301- 594-2242, jerkinsa@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: July 2, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-14648 Filed 7-6-18; 8:45 am] BILLING CODE 4140-01-P
![31762 Federal Register / Vol. 83, No. 131 / Monday, July 9, 2018 / Notices
any rights for any person and is not Place: National Institutes of Health, 6701 as amended. The grant applications and
binding on FDA or the public. You can Rockledge Drive, Bethesda, MD 20892 the discussions could disclose
use an alternative approach if it satisfies (Telephone Conference Call). confidential trade secrets or commercial
Contact Person: Denise Wiesch, Ph.D.,
the requirements of the applicable property such as patentable material,
Scientific Review Officer, Center for
statutes and regulations. This guidance Scientific Review, National Institutes of and personal information concerning
is not subject to Executive Order 12866. Health, 6701 Rockledge Drive, Room 3138, individuals associated with the grant
II. Paperwork Reduction Act of 1995 MSC 7770, Bethesda, MD 20892, (301) 437– applications, the disclosure of which
3478, wieschd@csr.nih.gov. would constitute a clearly unwarranted
This guidance refers to previously Name of Committee: Center for Scientific invasion of personal privacy.
approved collections of information Review Special Emphasis Panel; Networks Name of Committee: National Institute of
found in FDA regulations. These and Behavior in Psychiatric Disorders. Diabetes and Digestive and Kidney Diseases
collections of information are subject to Date: July 25, 2018. Special Emphasis Panel; Environmental
review by the Office of Management and Time: 2:00 p.m. to 5:00 p.m. Determinants of Diabetes.
Budget (OMB) under the Paperwork Agenda: To review and evaluate grant Date: July 9, 2018.
Reduction Act of 1995 (44 U.S.C. 3501– applications. Time: 1:00 p.m. to 3:30 p.m.
3520). The collections of information in Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant
21 CFR parts 601 and 640, and Form Rockledge Drive, Bethesda, MD 20892 applications.
(Telephone Conference Call).
FDA 356h have been approved under Place: National Institutes of Health, Two
Contact Person: Julius Cinque, MS, Democracy Plaza, 6707 Democracy
OMB control number 0910–0338; and Scientific Review Officer, Center for
the collections of information in 21 CFR Boulevard, Bethesda, MD 20892 (Telephone
Scientific Review, National Institutes of Conference Call).
parts 606 and 630 have been approved Health, 6701 Rockledge Drive, Room 5186,
under OMB control number 0910–0116. Contact Person: Elena Sanovich, Ph.D.,
MSC 7846, Bethesda, MD 20892, (301) 435–
Scientific Review Officer, Review Branch,
1252, cinquej@csr.nih.gov.
III. Electronic Access DEA, NIDDK, National Institutes of Health,
Name of Committee: Center for Scientific Room 7351, 6707 Democracy Boulevard,
Persons with access to the internet Review Special Emphasis Panel; PAR17–158: Bethesda, MD 20892–2542, 301–594–8886,
may obtain the guidance at either Epigenomes and Connectomes in Psychiatric sanoviche@mail.nih.gov.
https://www.fda.gov/Biologics Disorders.
This notice is being published less than 15
BloodVaccines/GuidanceCompliance Date: July 26, 2018.
days prior to the meeting due to the timing
RegulatoryInformation/Guidances/ Time: 2:00 p.m. to 5:00 p.m.
limitations imposed by the review and
default.htm or https:// Agenda: To review and evaluate grant
funding cycle.
www.regulations.gov. applications.
Place: National Institutes of Health, 6701 Name of Committee: National Institute of
Dated: June 28, 2018. Rockledge Drive, Bethesda, MD 20892 Diabetes and Digestive and Kidney Diseases
Leslie Kux, (Telephone Conference Call). Special Emphasis Panel; Review of Planning
Contact Person: Julius Cinque, MS, Grant Application (U34).
Associate Commissioner for Policy.
Scientific Review Officer, Center for Date: July 12, 2018.
[FR Doc. 2018–14537 Filed 7–6–18; 8:45 am] Time: 6:00 p.m. to 7:30 p.m.
Scientific Review, National Institutes of
BILLING CODE 4164–01–P
Health, 6701 Rockledge Drive, Room 5186, Agenda: To review and evaluate grant
MSC 7846, Bethesda, MD 20892, (301) 435– applications.
1252, cinquej@csr.nih.gov. Place: National Institutes of Health, Two
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
Democracy Plaza, 6707 Democracy
HUMAN SERVICES Boulevard, Bethesda, MD 20892 (Telephone
Program Nos. 93.306, Comparative Medicine;
Conference Call).
93.333, Clinical Research, 93.306, 93.333,
National Institutes of Health Contact Person: Barbara A. Woynarowska,
93.337, 93.393–93.396, 93.837–93.844,
Ph.D., Scientific Review Officer, Review
93.846–93.878, 93.892, 93.893, National
Center for Scientific Review; Notice of Institutes of Health, HHS)
Branch, DEA, NIDDK, National Institutes of
Closed Meetings Health, Room 754, 6707 Democracy
Dated: July 3, 2018. Boulevard, Bethesda, MD 20892–5452, (301)
Pursuant to section 10(d) of the Sylvia L. Neal, 402–7172, woynarowskab@niddk.nih.gov.
Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory This notice is being published less than 15
amended, notice is hereby given of the Committee Policy. days prior to the meeting due to the timing
following meetings. [FR Doc. 2018–14647 Filed 7–6–18; 8:45 am] limitations imposed by the review and
The meetings will be closed to the funding cycle.
BILLING CODE 4140–01–P
public in accordance with the Name of Committee: National Institute of
provisions set forth in sections Diabetes and Digestive and Kidney Diseases
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND
Special Emphasis Panel; NIDDK U34
as amended. The grant applications and Telephone Review.
HUMAN SERVICES Date: July 13, 2018.
the discussions could disclose
confidential trade secrets or commercial Time: 3:30 p.m. to 4:30 p.m.
National Institutes of Health Agenda: To review and evaluate grant
property such as patentable material,
applications.
and personal information concerning National Institute of Diabetes and Place: National Institutes of Health, Two
individuals associated with the grant Digestive and Kidney Diseases; Notice Democracy Plaza, 6707 Democracy
applications, the disclosure of which of Closed Meetings Boulevard, Bethesda, MD 20892 (Telephone
would constitute a clearly unwarranted Conference Call).
sradovich on DSK3GMQ082PROD with NOTICES
invasion of personal privacy. Pursuant to section 10(d) of the Contact Person: Xiaodu Guo, MD, Ph.D.,
Federal Advisory Committee Act, as Scientific Review Officer, Review Branch,
Name of Committee: Center for Scientific amended, notice is hereby given of the
Review Special Emphasis Panel; PAR Panel: DEA, NIDDK, National Institutes of Health,
Pregnancy in Women with Disabilities.
following meetings. Room 7023, 6707 Democracy Boulevard,
Date: July 23, 2018. The meetings will be closed to the Bethesda, MD 20892–5452, (301) 594–4719,
Time: 12:00 p.m. to 1:30 p.m. public in accordance with the guox@extra.niddk.nih.gov.
Agenda: To review and evaluate grant provisions set forth in sections This notice is being published less than 15
applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., days prior to the meeting due to the timing
VerDate Sep<11>2014 18:00 Jul 06, 2018 Jkt 244001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\09JYN1.SGM 09JYN1](https://thefederalregister.org/doc/83_FR_31893/page/1.svg)
![Federal Register / Vol. 83, No. 131 / Monday, July 9, 2018 / Notices 31763
limitations imposed by the review and DEPARTMENT OF HOMELAND II. Background and Purpose
funding cycle. SECURITY Under 33 CFR 127.007(a), an owner or
Name of Committee: National Institute of operator planning to build a new facility
Diabetes and Digestive and Kidney Diseases Coast Guard
handling liquefied natural gas (LNG), or
Special Emphasis Panel; Mechanisms and [Docket No. USCG–2017–0915] an owner or operator planning new
Treatments of Lower Urinary Tract
construction to expand or modify
Dysfunction after Spinal Cord Injury. Waterway Suitability Assessment for marine terminal operations in an
Date: July 23, 2018. Operation of Liquefied Natural Gas existing facility handling LNG, where
Time: 1:00 p.m. to 4:00 p.m. Terminal; Cameron, LA the construction, expansion, or
Agenda: To review and evaluate grant
applications. Coast Guard, DHS.
AGENCY: modification would result in an increase
Place: National Institutes of Health, Two in the size and/or frequency of LNG
Notice of inquiry; request for
ACTION:
Democracy Plaza, 6707 Democracy marine traffic on the waterway
comments.
Boulevard, Bethesda, MD 20892 (Telephone associated with the proposed facility or
Conference Call). SUMMARY: We are requesting your modification to an existing facility, must
Contact Person: Paul A. Rushing, Ph.D., comments on a Letter of Intent and submit a Letter of Intent (LOI) to the
Scientific Review Officer, Review Branch, Preliminary Waterway Suitability Captain of the Port of the zone in which
DEA, NIDDK, National Institutes of Health, Assessment we received from Sabine the facility is or will be located. Under
Room 7345, 6707 Democracy Boulevard, Pass LNG, L.P. (SPLNG) regarding 33 CFR 127.007(e), an owner or operator
Bethesda, MD 20892–5452, (301) 594–8895, SPLNG’s plans to construct a new berth planning such new construction or
rushingp@extra.niddk.nih.gov. at its Cameron Parish, LA facility and to expansion of an existing facility must
Name of Committee: National Institute of increase the number of liquefied natural also file or update a Waterway
Diabetes and Digestive and Kidney Diseases gas vessels calling at the facility from Suitability Assessment (WSA) that
Special Emphasis Panel; Urologic P20 approximately 400 to 580 annually. The addresses the proposed increase in LNG
Applications. Coast Guard is notifying the public of marine traffic in the associated
Date: August 2–3, 2018. this proposed increase in LNG marine waterway.
Time: 8:00 a.m. to 1:00 p.m. traffic on the Sabine-Neches Waterway Under 33 CFR 127.009, after receiving
Agenda: To review and evaluate grant and is soliciting comments relevant to an LOI, the Captain of the Port issues a
applications. the Coast Guard’s preparation of a Letter Letter of Recommendation (LOR) as to
Place: Embassy Suites at the Chevy Chase of Recommendation for issuance to the the suitability of the waterway for LNG
Pavilion, 4300 Military Road NW, federal, state, or local agency with marine traffic to the appropriate
Washington, DC 20015. jurisdiction over the proposed facility. jurisdictional authorities. The LOR is
Contact Person: Ryan G. Morris, Ph.D., based on a series of factors listed in 33
DATES: Comments and related material
Scientific Review Officer, Review Branch, CFR 127.009 that relate to the physical
DEA, NIDDK, National Institutes of Health, must be received on or before August 8,
2018. nature of the affected waterway and
Room 7015, 6707 Democracy Boulevard, issues of safety and security associated
Bethesda, MD 20892–2542, 301–594–4721, ADDRESSES: You may submit comments
with LNG marine traffic on the affected
ryan.morris@nih.gov. identified by docket number USCG–
waterway.
Name of Committee: National Institute of 2017–0915 using the Federal
Diabetes and Digestive and Kidney Diseases eRulemaking Portal at http:// III. Information Requested
Special Emphasis Panel; Diabetes Ancillary www.regulations.gov. See the ‘‘Public On January 29, 2018, Sabine Pass
Studies (R01). Participation and Request for LNG, L.P. (SPLNG), located in Cameron
Date: August 2, 2018. Comments’’ portion of the Parish, LA, submitted an LOI and
Time: 1:30 p.m. to 4:30 p.m. SUPPLEMENTARY INFORMATION section Preliminary WSA regarding the
Agenda: To review and evaluate grant below for further instructions on company’s proposed plans to develop a
applications. submitting comments. new marine berth and expand the
Place: National Institutes of Health, Two FOR FURTHER INFORMATION CONTACT: If number of vessels calling on the facility
Democracy Plaza, 6707 Democracy you have questions about this notice of each year from approximately 400 to
Boulevard, Bethesda, MD 20892 (Telephone inquiry, call or email Mr. Scott K. 580. The purpose of this notice is to
Conference Call). Whalen, Vessel Traffic Service Director,
Contact Person: Ann A. Jerkins, Ph.D.,
solicit public comments on the
Marine Safety Unit Port Arthur, U.S. proposed increase in LNG marine traffic
Scientific Review Officer, Review Branch,
Coast Guard; telephone 409–719–5086, on the Sabine-Neches Waterway. The
DEA, NIDDK, National Institutes of Health,
email Scott.K.Whalen@uscg.mil. Coast Guard believes that public input
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242, SUPPLEMENTARY INFORMATION: may be useful to the Captain of the Port
jerkinsa@niddk.nih.gov. Marine Safety Unit Port Arthur (COTP)
I. Table of Abbreviations
(Catalogue of Federal Domestic Assistance with respect to validating the
Program Nos. 93.847, Diabetes, CFR Code of Federal Regulations information provided in SPLNG’s
Endocrinology and Metabolic Research; COTP Captain of the Port Marine Preliminary WSA and development of
93.848, Digestive Diseases and Nutrition Safety Unit Port Arthur the LOR. A brief summary of SPLNG’s
Research; 93.849, Kidney Diseases, Urology DHS Department of Homeland proposal is available in the docket
and Hematology Research, National Institutes Security where indicated under ADDRESSES.
On January 24, 2011, the Coast Guard
sradovich on DSK3GMQ082PROD with NOTICES
of Health, HHS) LNG Liquefied Natural Gas
LOI Letter of Intent published Navigation and Vessel
Dated: July 2, 2018.
LOR Letter of Recommendation Inspection Circular (NVIC) 01–2011,
David D. Clary, NVIC Navigation and Vessel titled ‘‘Guidance Related to Waterfront
Program Analyst, Office of Federal Advisory Inspection Circular Liquefied Natural Gas (LNG) Facilities’’.
Committee Policy. U.S.C. United States Code NVIC 01–2011 provides guidance for
[FR Doc. 2018–14648 Filed 7–6–18; 8:45 am] WSA Waterway Suitability owners and operators seeking approval
BILLING CODE 4140–01–P Assessment to build and operate LNG facilities. The
VerDate Sep<11>2014 18:00 Jul 06, 2018 Jkt 244001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\09JYN1.SGM 09JYN1](https://thefederalregister.org/doc/83_FR_31893/page/2.svg)
Document Created: 2018-07-07 00:42:40
Document Modified: 2018-07-07 00:42:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | July 9, 2018. | |
| FR Citation | 83 FR 31762 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR